EmilySuzanneReisenbichlerMD

PubMed

• 15 citations
  Multi-institutional Assessment of Pathologist Scoring HER2 Immunohistochemistry.
  Charles J Robbins, Aileen I Fernandez, Gang Han, Serena Wong, Malini Harigopal, Mirna Podoll, Kamaljeet Singh, Amy Ly, M Gabriela Kuba, Hannah Wen, Mary Ann Sanders, J...> ;Modern Pathology. 2023 Jan 1
• 2 citations
  PD-L1 protein expression in relation to recurrence score values in early-stage ER + breast cancer.
  Mariya Rozenblit, Kim Blenman, Malini Harigopal, Emily Reisenbichler, Kamaljeet Singh, Tao Qing, Eiman Ibrahim, Shakti Ramkissoon, Sem Asmelash, Hao-Kuen Lin, Mustimbo...> ;Breast Cancer Research and Treatment. 2022 Nov 1
• 2 citations
  Standardizing Pathologic Evaluation of Breast Carcinoma After Neoadjuvant Chemotherapy.
  Sunati Sahoo, Gregor Krings, Yunn-Yi Chen, Jodi M Carter, Beiyun Chen, Hua Guo, Hanina Hibshoosh, Emily Reisenbichler, Fang Fan, Shi Wei, Laila Khazai, Ronald Balassan...> ;Archives of Pathology & Laboratory Medicine. 2022 May 1
• 1 citations
  Clinical Outcomes and Immune Markers by Race in a Phase I/II Clinical Trial of Durvalumab Concomitant with Neoadjuvant Chemotherapy in Early-Stage TNBC.
  Julia Foldi, Adriana Kahn, Andrea Silber, Tao Qing, Emily Reisenbichler, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Anees Chagpar, Tristen Park, Ad...> ;Clinical Cancer Research. 2022 Sep 1
• 6 citations
  Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer.
  Michal Marczyk, Tao Qing, Tess O'Meara, Vesal Yagahoobi, Vasiliki Pelekanou, Yalai Bai, Emily Reisenbichler, Kimberly S Cole, Xiaotong Li, Vignesh Gunasekharan, Eiman ...> ;NPJ Breast Cancer. 2022 Jul 22
• 12 citations
  Predictive Markers of Response to Neoadjuvant Durvalumab with Nab-Paclitaxel and Dose-Dense Doxorubicin/Cyclophosphamide in Basal-Like Triple-Negative Breast Cancer.
  Kim R M Blenman, Michal Marczyk, Thomas Karn, Tao Qing, Xiaotong Li, Vignesh Gunasekharan, Vesal Yaghoobi, Yalai Bai, Eiman Y Ibrahim, Tristen Park, Andrea Silber, Den...> ;Clinical Cancer Research. 2022 Jun 13
• 6 citations
  Determination of the number of observers needed to evaluate a subjective test and its application in two PD-L1 studies.
  Gang Han, Michael J Schell, Emily S Reisenbichler, Bohong Guo, David L Rimm> ;Statistics in Medicine. 2022 Apr 15
• 135 citations
  Examination of Low ERBB2 Protein Expression in Breast Cancer Tissue.
  Aileen I Fernandez, Matthew Liu, Andrew Bellizzi, Jane Brock, Oluwole Fadare, Krisztina Hanley, Malini Harigopal, Julie M Jorns, M Gabriela Kuba, Amy Ly, Mirna Podoll,...> ;JAMA Oncology. 2022 Apr 1
• 1 citations
  Author Correction: Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
  Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal Fischbach, Justin Persico, Kerin Adelson, Anamika Katoch, Nina Horowitz, Donald Lannin, Anees Ch...> ;NPJ Breast Cancer. 2022 Feb 3
• 4 citations
  Cryptococcal chest wall mass and rib osteomyelitis associated with the use of fingolimod: A case report and literature review.
  Kent Carpenter, Ali Etemady-Deylamy, Victoria Costello, Mohammad Khasawneh, Robin Chamberland, Katherine Tian, Maureen Donlin, Brenda Moreira-Walsh, Emily Reisenbichle...> ;Frontiers in Medicine. 2022 Jan 1
• 1 citations
  Stromal Changes are Associated with High P4HA2 Expression in Ductal Carcinoma in Situ of the Breast.
  Marie Colombe Agahozo, Mieke van Bockstal, Pieter J Westenend, Christine Galant, Kathleen Lambein, Emily Reisenbichler, Renata Sinke, Serena Wong, Carolien H M van Deu...> ;Journal of Mammary Gland Biology and Neoplasia. 2021 Dec 1
• 16 citations
  A Novel Immunomodulatory 27-Gene Signature to Predict Response to Neoadjuvant Immunochemotherapy for Primary Triple-Negative Breast Cancer.
  Toshiaki Iwase, Kim R. M. Blenman, Xiaotong Li, Emily Reisenbichler, Robert S. Seitz, David R. Hout, Tyler J. Nielsen, Brock L. Schweitzer, Daniel B. Bailey, Yichao Sh...> ;Cancers. 2021 Sep 28
• 41 citations
  Deep learning trained on hematoxylin and eosin tumor region of Interest predicts HER2 status and trastuzumab treatment response in HER2+ breast cancer.
  Saman Farahmand, Aileen Fernandez, Fahad Shabbir Ahmed, David L. Rimm, Jeffrey H. Chuang, Emily Reisenbichler, Kourosh Zarringhalam> ;Modern Pathology. 2021 Sep 7
• 13 citations
  Interobserver variability in the assessment of stromal tumor-infiltrating lymphocytes (sTILs) in triple-negative invasive breast carcinoma influences the association w...
  Mieke R Van Bockstal, Aline François, Serdar Altinay, Laurent Arnould, Maschenka Balkenhol, Glenn Broeckx, Octavio Burguès, Cecile Colpaert, Franceska Dedeurwaerdere, ...> ;Modern Pathology. 2021 Jul 3
• 2 citations
  HER-2/neu-positive breast cancer neoadjuvant chemotherapy response after implementation of 2018 ASCO/CAP focused update.
  Lin Wang, Jaya Ruth Asirvatham, Yanlin Ma, Emily Reisenbichler, Julie M. Jorns> ;The Breast Journal. 2021 May 20
• 14 citations
  Characteristics and Long-Term Risk of Breast Angiosarcoma
  Ann-Kristin U. Friedrich, Emily Reisenbichler, Danielle R. Heller, Justin M. LeBlanc, Tristen S. Park, Brigid K. Killelea, Donald R. Lannin> ;Annals of Surgical Oncology. 2021 Feb 18
• 29 citations
  Neoadjuvant durvalumab plus weekly nab-paclitaxel and dose-dense doxorubicin/cyclophosphamide in triple-negative breast cancer.
  Julia Foldi, Andrea Silber, Emily Reisenbichler, Kamaljeet Singh, Neal A. Fischbach, Justin Persico, Kerin B. Adelson, Anamika Katoch, Nina R. Horowitz, Donald R. Lann...> ;NPJ Breast Cancer. 2021 Feb 8
• Expression of lymphoid enhancer-binding factor 1 in breast fibroepithelial lesions
  Po-Han Chen, Veerle Bossuyt, Emily Reisenbichler> ;Human Pathology. 2021 Feb 1
• 11 citations
  LMNA-NTRK1 rearranged mesenchymal tumor (lipofibromatosis-like neural tumor) mimicking pigmented dermatofibrosarcoma protuberans.
  Gauri Panse, Emily Reisenbichler, Matija Snuderl, Wei Lien Wang, William B. Laskin, George Jour> ;Journal of Cutaneous Pathology. 2021 Feb 1
• 10 citations
  Reciprocal expression of Annexin A6 and RasGRF2 discriminates rapidly growing from invasive triple negative breast cancer subsets.
  Olga Y. Korolkova, Sarrah E. Widatalla, Diva S. Whalen, Gladys N. Nangami, Adeniyi Abimbola, Stephen D. Williams, Heather K. Beasley, Emily Reisenbichler, Mary Kay Was...> ;Plos One. 2020 Apr 16
• 91 citations
  Prospective multi-institutional evaluation of pathologist assessment of PD-L1 assays for patient selection in triple negative breast cancer
  Emily Reisenbichler, Gang Han, Andrew M. Bellizzi, Veerle Bossuyt, Jane E. Brock, Kimberly Cole, Oluwole Fadare, Omar Hameed, Krisztina Z. Hanley, Beth T. Harrison, M....> ;Modern Pathology. 2020 Apr 16
• 120 citations
  The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clin...
  Paula I. Gonzalez-Ericsson, Elisabeth Specht Stovgaard, Luz F. Sua, Emily Reisenbichler, Zuzana Kos, Jodi M. Carter, Stefan Michiels, John Le Quesne, Torsten O. Nielse...> ;The Journal of Pathology. 2020 Apr 1
• 23 citations
  Interobserver Variability in Upfront Dichotomous Histopathological Assessment of Ductal Carcinoma in Situ of the Breast: The DCISion Study
  Hélène Dano, Serdar Altinay, Laurent Arnould, Noella Bletard, Cecile Colpaert, Franceska Dedeurwaerdere, Benjamin F. Dessauvagie, Valérie Duwel, Giuseppe Floris, Steph...> ;Modern Pathology. 2020 Mar 1
• 10 citations
  Association between low estrogen receptor positive breast cancer and staining performance.
  Wei Wei, Sandra Martinez-Morilla, David L Rimm, Emily S Reisenbichler, Caruana, D., Dennis Caruana> ;NPJ Breast Cancer. 2020 Jan 1
• Current Procedural Terminology Coding in an Academic Breast Pathology Service.
  Emily Reisenbichler, Andrea Barbieri, Vinita Parkash> ;The American Journal of Surgical Pathology. 2020 Apr 1
• Join now to see all

Journal Articles

• Intraoperative Sentinel Lymph Node Evaluation: Optimizing Surgical Pathology Practices in an Era of Changing Clinical Management  
  Margaret L Compton, Emily S Reisenbichler, Raeshell S Sweeting, ScienceDirect